Top insulin maker Novo caught up in China's widening drug probes

COPENHAGEN/LONDON (Reuters) – Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S , the world’s biggest maker of insulin, in the latest sign of a widening investigation into Western drugmakers.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.